Matthew Spencer Slivka

D.M.D. | Dentist



  
  8275 N Silverbell Rd, #1, Tucson
  Arizona, 85743-7384

  520-305-5336    Maps & Directions
Matthew Spencer Slivka is a Tucson, Arizona based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 8275 N Silverbell Rd, #1, Tucson. Patients can reach him at 520-305-5336.
Matthew Spencer Slivka is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Matthew Spencer Slivka speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Matthew Spencer Slivka
Specialization: Dentist
Gender:Male
Credentials: D.M.D.
Accepts Medicare Assignment:May Accept
Practice Address:8275 N Silverbell Rd, #1, Tucson,
Arizona, 85743-7384
Phone:520-305-5336
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8921303397
Enrollment ID: I20160223000864
NPI Number: 1770742579
NPI Enumeration Date: 05 Jun, 2008
NPI Last Update On: 16 Apr, 2010

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 7981 N Lime Star Dr,
Tucson, Arizona
Zip: 85743-7337
Phone Number: 520-544-5660
Patients can reach Matthew Spencer Slivka at 8275 N Silverbell Rd, #1, Tucson, Arizona or can call to book an appointment on 520-305-5336. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: